Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation.
We report the results of an investigation of the inhibition of the ATP-mediated HIV-1 reverse transcriptase catalyzed phosphorolysis in vitro of AZT from AZT-terminated DNA primers by a series of 42 bisphosphonates. The four most active compounds possess neutral, halogen-substituted phenyl or biphenyl sidechains and have IC(50) values < 1 microM in excision inhibition assays. Use of two comparative molecular similarity analysis methods to analyze these inhibition results yielded a classification model with an overall accuracy of 94%, and a regression model having good accord with experiment (q(2)=0.63, r(2)=0.91), with the experimental activities being predicted within, on average, a factor of 2. The most active species had little or no toxicity against three human cell lines (IC(50)(avg) > 200 microM). These results are of general interest since they suggest that it may be possible to develop potent bisphosphonate-based AZT-excision inhibitors with little cellular toxicity, opening up a new route to restoring AZT sensitivity in otherwise resistant HIV-1 strains.
Song
Yongcheng
Y
Department of Chemistry, University of Illinois at Urbana-Champaign, 600 South Mathews Avenue, Urbana, IL 61801, USA.
Chan
Julian M W
JM
Tovian
Zev
Z
Secrest
Aaron
A
Nagy
Eva
E
Krysiak
Kilannin
K
Bergan
Kyle
K
Parniak
Michael A
MA
Oldfield
Eric
E
D000255:Adenosine Triphosphate / Q000378:metabolism*; D019380:Anti-HIV Agents / Q000737:chemistry / Q000494:pharmacology*; D002384:Catalysis; D045744:Cell Line, Tumor; D017931:DNA Primers / Q000378:metabolism; D054306:Dideoxynucleotides / Q000737:chemistry / Q000378:metabolism*; D004164:Diphosphonates / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors*; D006219:Halogens / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D020128:Inhibitory Concentration 50; D010756:Phosphoric Acids / Q000737:chemistry / Q000378:metabolism; D021281:Quantitative Structure-Activity Relationship; D012044:Regression Analysis; D013942:Thymine Nucleotides / Q000737:chemistry / Q000378:metabolism*; D015215:Zidovudine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism
D019380:Anti-HIV Agents; D017931:DNA Primers; D054306:Dideoxynucleotides; D004164:Diphosphonates; D004791:Enzyme Inhibitors; D006219:Halogens; D010756:Phosphoric Acids; D013942:Thymine Nucleotides; C057287:3'-azido-3'-deoxythymidine 5'phosphate; D015215:Zidovudine; D000255:Adenosine Triphosphate; D054303:HIV Reverse Transcriptase
J Med Chem. 1994 Nov 25;37(24):4130-46
7990113
J Virol. 2001 May;75(10):4832-42
11312355
J Virol. 1996 Sep;70(9):5930-4
8709214
J Am Chem Soc. 2006 Nov 15;128(45):14485-97
17090032
J Biol Chem. 2006 Sep 22;281(38):27744-52
16829515
J Med Chem. 2005 Sep 22;48(19):6128-39
16162013
J Med Chem. 2003 Nov 20;46(24):5171-83
14613320
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4884-7
1534409
J Comput Aided Mol Des. 1993 Oct;7(5):587-619
8294948
J Med Chem. 2002 Aug 15;45(17):3721-38
12166945
Science. 1989 Dec 1;246(4934):1155-8
2479983
J Med Chem. 2005 Apr 21;48(8):2957-63
15828834
Mol Cell. 1999 Jul;4(1):35-43
10445025
J Med Chem. 2006 Jan 12;49(1):215-23
16392806
Biochemistry. 2007 Jan 23;46(3):828-36
17223704
Protein Expr Purif. 1996 Feb;7(1):27-32
9172779
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1934-8
1371886
J Virol. 1998 Jun;72(6):5093-8
9573280
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7829-34
16684881
Proc Natl Acad Sci U S A. 1985 Oct;82(20):7096-100
2413459
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13471-6
9811824
J Virol. 1996 Nov;70(11):8010-8
8892925
Biochem J. 2007 Jul 1;405(1):165-71
17355225
Bone. 1987;8 Suppl 1:S35-41
2825741